نبذة مختصرة : Actuality. One of the significant ophthalmic diseases is a dry form age-related macular degeneration (dAMD). The issues of etiology and pathogenesis are not completely cleared nowadays and they signify the subject of discussion. There are risk factors of dAMD (age, heredity, lifestyle etc.) which can cause metabolic disorders, changes hemorheological parameters which promote activation of druseogenesis and as a result an angiogenesis. Mostly an outcome of dAMD is geographical atrophy and decrease of central visual acuity. At the same time, it is known that similar metabolic and rheological disorders detected in other diseases are effectively corrected by extracorporeal rheoaferesis, in particular, using double filtration plasmapheresis. Thus, using of extracorporeal rheoaferesis with dAMD patients is pathogenetically well-reasoned, but in the available literature, a correct analysis of the effectiveness and safety of double filtration plasmapheresis in patients with intermediate stage of dAMD is presented poorly.Objective. To study along with data of OCT, OCT angiography, visometry, microperimetry and electroretinography structural and functional changes in the macular zone in patients with a dry form of age-related macular degeneration after the using of double filtration plasmapheresis.Patients and methods. The study included 63 patients (94 eyes) with an intermediate stage of dAMD. The patients were separated into two groups randomly. The first (main) group included 34 patients (52 eyes) who were performed double filtration plasmapheresis (DFPP) on an OctoNova device using a Plasmaflo plasma filter and a Cascadeflo EC40 fractionator in the amount of 4 procedures with a frequency of 1 time per week for 1 month. The second group (control) included 29 patients (42 eyes) who did not receive any specific treatment. In the main group of patients, OCT, OCT angiography, microperimetry and electroretinography were additionally performed in addition to standard ophthalmological examination before the DFPP course, after ...
Relation: https://www.ophthalmojournal.com/opht/article/view/2300/1194; Измайлов АС. Лечение «сухой» формы возрастной макулярной дегенерации. РМЖ «Клиническая Офтальмология». 2017;1:56–60. doi:10.21689/2311-7729-2017-17-1-56-60.; Donders FC. Beiträge zur pathologischen Anatomie des Auges. Contributions to the pathologic anatomy of the eye. Archiv für Ophthalmologie. 1855;106–118.; Hutchinson J. Symmetrical central choroido-retinal disease occurring in senile persons. The Royal London Ophthalmic Hospital records and journal of ophthalmic medicine and surgery. 1874;231–244.; Haab O. Erkrankungen der Macula lutea. Disaes of the macula lutea. Centralblat für praktische Augenheilkunde. 1885;384–391.; Haab O. Atlas und Grundriss der Ophthalmoskopie und ophthalmoskopischen Diagnostik. Atlas and outline of ophthalmoscopy and ophthalmoskopic diagnostics. Lehmann: München, 1908;2.; Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973 Sep;90(3):206–217. doi:10.1001/archopht.1973.01000050208006.; Либман ЕС, Шахова ЕВ. Слепота и инвалидность вследствие патологии органа зрения в России. Вестник офтальмологии. 2006;122(1):209–214.; Коняев ДА, Попова ЕВ, Титов АА, Агарков НМ, Яблоков ММ, Аксёнов ВВ. Распространённость заболеваний глаза у пожилых — глобальная проблема современности. Здравоохранение Российской Федерации. 2021;65(1):62–68. doi:10.47470/0044-197X-2021-65-1-62-68.; Stahl A. The Diagnosis and Treatment of Age-Related Macular Degeneration. Dtsch Arztebl Int. 2020 Jul 20;117(29–30):513–520. doi:10.3238/arztebl.2020.0513.; Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014 Feb;2(2):e106–116. doi:10.1016/S2214-109X(13)70145-1.; Roh M, Laíns I, Shin HJ, Park DH, Mach S, Vavvas DG, Kim IK, Miller JW, Husain D, Miller JB. Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography. Br J Ophthalmol. 2019 Dec;103(12):1769–1776. doi:10.1136/bjophthalmol-2018-313316.; Johnson PT, Lewis JP, Talaga KC, Brown MN, Kappel PJ, Fisher SK, Anderson DH, Johnson LV. Drusen-Associated Degeneration in the Retina. Invest. Ophthalmol. Vis. Sci. 2003;44(10):4481–4488.; De Jong PTVM. Elusive drusen and changing terminology of AMD. Eye (Lond). 2018 May;32(5):904–914. doi:10.1038/eye.2017.298.; Мануилов АС, Бардаков СН, Апчел АВ, Бельских АН, Захаров МВ, Тишко ВВ, Иванов АМ. Опыт применения каскадной плазмофильтрации в комбинированном лечении системной красной волчанки на фоне программного гемодиализа. Вестник Российской Военно-медицинской академии. 2018;20(2):115–119. doi:10.17816/brmma12278.; Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W; AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 1;140(7):692–698. doi:10.1001/jamaophthalmol.2022.1640.; Huang Z, Deng KY, Deng YM, Hui YN, Song YP. Long-term outcomes of drusenoid pigment epithelium detachment in intermediate AMD treated with 577 nm subthreshold micropulse laser: a preliminary clinical study. Int J Ophthalmol. 2022 Mar 18;15(3):474–482. doi:10.18240/ijo.2022.03.16.; Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, McGuinness MB, Fletcher EL, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Lek JJ, Harper CA, Wickremasinghe SS, Sandhu SS, Baglin EK, Sharangan P, Braat S, Luu CD. Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group. Subthreshold Nanosecond Laser Intervention in AgeRelated Macular Degeneration: The LEAD Randomized Controlled Clinical Trial. Ophthalmology. 2019 Jun;126(6):829–838. doi:10.1016/j.ophtha.2018.09.015.; Brunner R, Widder RA, Walter P, Luke C, Godehardt E, € Bartz-Schmidt K-U, et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration––a randomized trial. Retina. 2000;20:483–491.; Swartz M, Rabetoy G. Treatment of non-exudative agerelated macular degeneration using membrane differential filtration apheresis. Invest Ophthalmol Vis Sci. 1999;40:319.; Klingel R, Fassbender C, Heibges A, Koch F, Nasemann J, Engelmann K, Carl T, Meinke M, Erdtracht B. RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration. Ther Apher Dial. 2010 Jun;14(3):276–286. doi:10.1111/j.1744-9987.2010.00807.x.; https://www.ophthalmojournal.com/opht/article/view/2300
_1.png)
Processing Request
No Comments.